Goldman Sachs’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-48,600
Closed -$2.27M 6102
2017
Q4
$2.27M Sell
48,600
-43,900
-47% -$2.17M ﹤0.01% 3686
2017
Q3
$4.68M Buy
92,500
+35,800
+63% +$1.67M ﹤0.01% 3214
2017
Q2
$2.83M Buy
56,700
+51,600
+1,012% +$2.41M ﹤0.01% 3548
2017
Q1
$216K Buy
+5,100
New +$226K ﹤0.01% 5682
2016
Q4
Sell
-1,100
Closed -$42K 6969
2016
Q3
$42K Sell
1,100
-400
-27% -$12.7K ﹤0.01% 6542
2016
Q2
$46K Buy
+1,500
New +$39.4K ﹤0.01% 6455
2015
Q4
Sell
-200
Closed -$6K 7231
2015
Q3
$6K Buy
+200
New +$6.29K ﹤0.01% 7188

Other funds holding HQY

Goldman Sachs's HQY Position: Q1 2026 in Review

Goldman Sachs reduced its HealthEquity (HQY) stake by 13% in Q1 2026, selling an estimated $10.1M and leaving 800,818 shares worth $66.9M. The position accounts for 0.01% of the portfolio, ranked #1340.

Goldman Sachs first reported a position in HQY in Q3 2014 and has held it in 46 quarters since. The position peaked at $107M in Q4 2024. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Goldman Sachs held 800,818 shares of HealthEquity worth $66.9M as of Q1 2026.
  • Goldman Sachs sold 123,431 HealthEquity shares in Q1 2026, an estimated $10.1M.
  • HealthEquity made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1340 holding.
  • Goldman Sachs first reported a position in HealthEquity in Q3 2014 and has held it in 46 quarters since.
  • Goldman Sachs's HealthEquity position peaked at $107M in Q4 2024.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.